September 9, 202010:00 AM - 11:00 AM PT
The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. In this Dialogue, Dr Raphael J. Landovitz of the University of California Los Angeles and Dr E. Turner Overton of the University of Alabama at Birmingham will discuss new findings and challenges regarding HIV preexposure prophylaxis (PrEP), along with the impact of the COVID-19 pandemic on PrEP use in the US. Recent data presented by Dr Landovitz at AIDS 2020 regarding long-acting, injectable PrEP, will also be included in the discussion.
A word of caution: The shelf life of the information in these dialogues is limited by the rapidly evolving science.
Please use this link to sign up: https://zoom.us/webinar/register/WN_O7pYkRvhS9WaCxOMt-3n5w
Zoom will send an email that includes a unique URL to join the Zoom activity and allow you to add this information to your calendar. Zoom will send 1-day and 1-hour reminders.Sign Up